Introducing the VP of Business Development at MedRhythms
April 2nd, 2019
PORTLAND, Maine - MedRhythms, a Portland, Maine-based digital therapeutics company that uses sensors, software and music to measure and improve walking, has hired Jennifer Lavanture as the company’s VP of Business Development. In this role, Jennifer will be leading partnership strategy and execution for the products on MedRhythms’ platform.
Most recently, Jennifer served as Associate Director of Business Development at Rhodes Pharmaceuticals, where she led internal portfolio and product selection activities and executed numerous deals for co-development, licensing, and distribution of ANDA products. Jennifer also served as Director of Business Development and Portfolio at Putney, Inc., where she led the portfolio product selection process.
Jennifer began her professional career as a consultant at PharmaStrat, a New Jersey-based consulting and market research firm dedicated to biopharmaceutical market access, pricing, and reimbursement.
MedRhythms is in the process of developing its first digital therapeutic for post-stroke gait impairments. Future products on the MedRhythms platform will focus on other neurologic injuries and diseases.
MedRhythms, a privately held company headquartered in Portland, ME, is a digital therapeutics company that uses sensors, music, and AI to build evidence-based, neurologic interventions to measure and improve walking. The MedRhythms team has extensive experience in rehabilitation techniques that use music. The company began as a therapy services company that launched out of Spaulding Rehabilitation Hospital, which the US News & World Report named the No. 2 rehabilitation hospital in the country.
THIS MANAGEMENT COMMENTARY CONTAINS CERTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO THE COMPANY THAT ARE BASED ON INFORMATION AVAILABLE TO US AS OF THE DATE HEREOF. STATEMENTS THAT ARE NOT HISTORICAL FACTS, INCLUDING STATEMENTS ABOUT THE COMPANY’S BELIEFS, DESIGNS, ANTICIPATION, AIMS, GOALS, EXPECTATIONS AND POTENTIAL RESULTS ARE FORWARD-LOOKING STATEMENTS. IN ADDITION, THE WORDS “WILL,” “MAY,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “ESTIMATE,” “EXPECT,” “PROJECT,” “PLAN,” “SHOULD,” “COULD,” AND SIMILAR EXPRESSIONS, AND THEIR VARIATIONS AND NEGATIVES, AS THEY RELATE TO THE COMPANY OR THE FUTURE PERFORMANCE OF THE COMPANY, ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS. SUCH FORWARD-LOOKING STATEMENTS INVOLVE KNOWN AND UNKNOWN RISKS, UNCERTAINTIES, ASSUMPTIONS AND OTHER IMPORTANT FACTORS THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS, PERFORMANCE OR ACHIEVEMENTS OF RESULTS TO DIFFER MATERIALLY FROM ANY FUTURE RESULTS, PERFORMANCE OR ACHIEVEMENTS EXPRESSED OR IMPLIED BY SUCH FORWARD-LOOKING STATEMENTS. THIS MANAGEMENT COMMENTARY SPEAKS ONLY AS OF THE DATE HEREOF AND THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO UPDATE THIS COMMENTARY IN THE FUTURE.